Valsartan angiotensin-receptor blockers  

Aventis brand of valsartan - Nisis - CGP 48933 - walsartan - Vals - Provas - KalpressMiten - Tareg - Diovan - valsartan      

Select             pdf
Trial Studied trt Control trt patientstagsROB Trial resultAdverse eventsAll cause death

acute myocardial infarction  

VALIANT (valsartan+capropril), 2003     Valsartan+ACE inhibitor ACE inhibitor onlyLow risk of bias negative
VALIANT (valsartan alone), 2003     ValsartanCaptoprilLow risk of bias negative

atrial fibrillation  

GISSI-AF (Disertori), 2009      NCTvalsartanplaceboLow risk of bias negative
Val-HeFT (AF ancillary study), 2003   valsartanplacebosuggesting

diabetes type 2  

NAVIGATOR valsartan, 2010        NCTvalsartanplaceboLow risk of bias suggesting-9%

heart failure  

VALIDD, 2007    NCTvalsartanno valsartanLow risk of bias negative
Mazayev et al. (vs placebo), 1998     valsartanplaceboLow risk of bias -
V-HeFT, 1999     valsartan+ACE inhibitorACE inhibitor onlyLow risk of bias negative
Val-HeFT, 2001     valsartan+ACE inhibitorACE inhibitor onlyLow risk of bias suggesting 46%2%
HEAVEN, 2002     valsartanenalaprilLow risk of bias -
Mazayev et al. (vs lisinopril, 1998     valsartanLisinoprilExploratory -

hypertension  

VALIANT/Val, 2003       ValsartanCaptoprilLow risk of bias negative2%

impaired fasting glucose  

NAVIGATOR valsartan, 2010        NCTvalsartanplaceboLow risk of bias suggesting-9%